Quercetin decreases cardiac hypertrophic mediators and maladaptive coronary arterial remodeling in renovascular hypertensive rats without improving cardiac function (2023)
- Authors:
- USP affiliated authors: BERTOZI, GIULIANA - FMRP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP ; CASTRO, MICHELE MAZZARON DE - FMRP ; ROCHA, EDUARDO VIEIRA DA - FFCLRP ; FALCHETTI, FRANCISCO - FMRP ; MELLO, MARCELA MARIA BLASCKE DE - FMRP ; NOGUEIRA, RENATO CORRÊA - FMRP ; GOMES, BEATRIZ QUARESEMIN - FMRP
- Unidades: FMRP; FFCLRP
- DOI: 10.1007/s00210-022-02349-6
- Subjects: PRESSÃO SANGUÍNEA; CARDIOMEGALIA; VASOS CORONÁRIOS; HIPERTENSÃO; FARMACOTERAPIA; NEFROPATIAS
- Keywords: Quercetin; Hypertension; Oxidative stress; Cardiovascular remodeling; Matrix metalloproteinase
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Heidelberg
- Date published: 2023
- Source:
- Título do periódico: Naunyn-Schmiedeberg's Archives of Pharmacology
- ISSN: 0028-1298
- Volume/Número/Paginação/Ano: v. 396, n. 5, p. 939-949, 2023
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
ROCHA, Eduardo Vieira da et al. Quercetin decreases cardiac hypertrophic mediators and maladaptive coronary arterial remodeling in renovascular hypertensive rats without improving cardiac function. Naunyn-Schmiedeberg's Archives of Pharmacology, v. 396, n. 5, p. 939-949, 2023Tradução . . Disponível em: https://doi.org/10.1007/s00210-022-02349-6. Acesso em: 02 jun. 2024. -
APA
Rocha, E. V. da, Falchetti, F., Pernomian, L., Mello, M. M. B. de, Parente, J. M., Nogueira, R. C., et al. (2023). Quercetin decreases cardiac hypertrophic mediators and maladaptive coronary arterial remodeling in renovascular hypertensive rats without improving cardiac function. Naunyn-Schmiedeberg's Archives of Pharmacology, 396( 5), 939-949. doi:10.1007/s00210-022-02349-6 -
NLM
Rocha EV da, Falchetti F, Pernomian L, Mello MMB de, Parente JM, Nogueira RC, Gomes BQ, Bertozi G, Sanches-Lopes JM, Tanus-Santos JE, Castro MM de. Quercetin decreases cardiac hypertrophic mediators and maladaptive coronary arterial remodeling in renovascular hypertensive rats without improving cardiac function [Internet]. Naunyn-Schmiedeberg's Archives of Pharmacology. 2023 ; 396( 5): 939-949.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1007/s00210-022-02349-6 -
Vancouver
Rocha EV da, Falchetti F, Pernomian L, Mello MMB de, Parente JM, Nogueira RC, Gomes BQ, Bertozi G, Sanches-Lopes JM, Tanus-Santos JE, Castro MM de. Quercetin decreases cardiac hypertrophic mediators and maladaptive coronary arterial remodeling in renovascular hypertensive rats without improving cardiac function [Internet]. Naunyn-Schmiedeberg's Archives of Pharmacology. 2023 ; 396( 5): 939-949.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1007/s00210-022-02349-6 - On the origin of nitrosylated hemoglobin in COVID-19: endothelial NO capture or redox conversion of nitrite? experimental results and a cautionary note on challenges in translational research
- Matrix metalloproteinase (MMP)-2 activation by oxidative stress decreases aortic calponin-1 levels during hypertrophic remodeling in early hypertension
- The potential of stimulating nitric oxide formation in the treatment of hypertension
- Matrix metalloproteinase (MMP)-2 decreases calponin-1 levels and contributes to arterial remodeling in early hypertension
- Imbalance between matrix metalloproteinase (MMP)-2 and calponin-1 in early hypertensive vascular remodeling
- Targeting matrix metalloproteinases in disease conditions. [Editorial]
- Efeitos deletérios da interferência no ciclo êntero-salivar do nitrato/nitrito sobre o aparelho cardiovascular
- Mecanismos envolvidos no remodelamento vascular promovido pelo tratamento com omeprazol
- Matrix metalloproteinase (MMP)-2 diverges in regulate calponin-1 in conductance and resistance arteries in early hypertension induced vascular dysfunction and remodeling
- Quercetin decreases the activity of matrix metalloproteinase-2 and ameliorates vascular remodeling in renovascular hypertension
Informações sobre o DOI: 10.1007/s00210-022-02349-6 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
